Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

DeepMind

Microsoft brings its AI network to cardiology

Also launches cloud-based genomics service for its Azure platform

FDA approves AI-based decision support software

Viz.AI Contact alerts healthcare professionals if a patient is at risk of stroke

MSD outlines its AI needs in tech start-up programme

Continues its Velocity Health work with Wayra UK

Why AI might be the rep’s best friend

When looking for the next big thing in digital communication, there’s nothing bigger than the sweeping changes promised by artificial intelligence. There’s little doubt that AI is coming to pharma...

Anthill Agency

- PMLiVE

Artificial intelligence: could pharma lead the way?

Producing powerful, relevant user experiences will be one key area to target

- PMLiVE

Innovating patient care

As HCPs and healthcare systems alike strive to provide optimal patient care while managing in an environment that continues to be cost-constrained there is still room to further innovate patient...

- PMLiVE

Top ten tech trends

As technology continues to have a huge impact on society’s mental and physical health, what’s on the horizon for 2017?

PatientsLikeMe joins artificial intelligence alliance

The Digital Life Alliance is led by Chinese health-focused AI firm iCarbonX

- PMLiVE

2017 Trends in healthcare – how advances in technology are influencing the expert-patient relationship

In the 2017 trends edition of Perspective magazine, we explore how advances in technology are influencing the future of the expert-patient relationship and the role healthcare businesses can take in...

Blue Latitude Health

Celgene to apply machine learning to market access

Signs agreement for rights to GNS Healthcare's simulation platform

- PMLiVE

Healthcare and the artificial intelligence revolution

How technologists and healthcare professionals are working together to improve patient outcomes

Artificial intelligence firm licenses Janssen candidates for development

UK-based BenevolentAI aims to move them into late-stage trials by mid-2017

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links